Endoscopic Injection Therapy in Bleeding Peptic Ulcers. Low Mortality in a High Risk Population
Author(s) -
J. Balanzó,
Cándid Villanueva,
Jorge C. Espinós,
Sergio Sáinz,
Germán Soriano,
Dolors González,
Xavier Ríus,
J. Puig La Calle,
Francisco Vilardell
Publication year - 1992
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/1992/416485
Subject(s) - medicine , peptic , hemostasis , surgery , endoscopy , population , pneumonia , mortality rate , aspiration pneumonia , peptic ulcer , environmental health
Endoscoric injection therapy was performed in 341 patients consecutively admitted with a bleeding peptic ulcer at high risk of further hemorrhage, assessed by the presence of active arterial bleeding or a nonbleeding visible vessel at emergency endoscopy. Initial hemostasis was achieved in 111 of 119 actively bleeding patients (93%). Rebleeding ocurred in 75 cases (23%), at a mean interval of 53±52 h. A second emergency injection was a ttempted in 36 therapeutic failures, and was successful in 20 (55%). Emergency surgery was finally required in 52 patients (15%). Overall mortality was 4.9%. Major complications occurred in four patients (1.2%) (two perforations and two aspiration pneumonia); therefore, injection therapy is an effective and simple method for treating bleeding ulcers, achieving the initial control of hemorrhage in a majority of cases although the rate of further hemorrhage is not negligible and complications are not irrelevant
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom